Allogeneic BMT
Showing 1 - 25 of 2,605
Hematologic Malignancies Trial in Baltimore (drug, radiation, procedure)
Recruiting
- Hematologic Malignancies
- Fludarabine
- +7 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 14, 2022
Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid
Recruiting
- Previously Treated Myelodysplastic Syndrome
- +3 more
- Fludarabine Phosphate
- +9 more
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Jan 7, 2022
Acute Leukemia, MDS Trial in Chicago (device, drug, other)
Recruiting
- Acute Leukemia
- MDS
- Arm1
- Arm 1
-
Chicago, IllinoisUniversity of Illinois Cancer Center
Oct 13, 2022
Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in
Active, not recruiting
- Hematopoietic Cell Transplantation Recipient
- +3 more
- Allogeneic Bone Marrow Transplantation
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Primary Immunodeficiency, PID Trial in Pittsburgh (CD3/CD19 neg allogeneic BMT)
Active, not recruiting
- Primary Immunodeficiency
- PID
- CD3/CD19 neg allogeneic BMT
-
Pittsburgh, PennsylvaniaChildren's Hospital of Pittsburgh of University of Pittsburgh Me
Oct 6, 2021
Multiple Myeloma Trial in United States (Allogeneic HSCT, Fludarabine, Melphalan)
Completed
- Multiple Myeloma
- Allogeneic HSCT
- +5 more
-
Birmingham, Alabama
- +14 more
Jan 25, 2022
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Allogeneic Hematopoietic Stem Cell
Completed
- Acute Lymphoblastic Leukemia in Remission
- +6 more
- Allogeneic Bone Marrow Transplantation
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Dec 15, 2021
Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency, Immune System Diseases Trial in Bethesda,
Recruiting
- Primary T-cell Immunodeficiency Disorders
- +4 more
- Immunosuppression Only Conditioning -Closed with amendment L
- +4 more
-
Bethesda, Maryland
- +1 more
Jul 26, 2022
Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage Trial in United States (radiation, drug,
Recruiting
- Acute Biphenotypic Leukemia
- +11 more
- Total-Body Irradiation
- +8 more
-
Los Angeles, California
- +9 more
Aug 19, 2022
Acute Myeloid Leukemia (AML) Trial in Charlotte (Allogeneic HCT, Consolidation chemo)
Terminated
- Acute Myeloid Leukemia (AML)
- Allogeneic HCT
- Consolidation chemotherapy
-
Charlotte, North CarolinaLevine Cancer Institute
Apr 19, 2022
Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia, Congenital Pure Red Cell Aplasia Trial in United
Recruiting
- Bone Marrow Failure Syndrome
- +6 more
- Treosulfan
- +7 more
-
Los Angeles, California
- +23 more
Aug 15, 2022
Leukemia, Lymphoma, Blood Cancer Trial in Baltimore (Bone Marrow Transplant (BMT))
Recruiting
- Leukemia
- +5 more
- Bone Marrow Transplant (BMT)
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 14, 2022
Stem Cell Transplant Complications, Myeloma, Lymphoma Trial in Cleveland (physical therapy consult, Cognitive Assessment, Cancer
Recruiting
- Stem Cell Transplant Complications
- +3 more
- physical therapy consult
- +8 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
May 24, 2022
Acute Myeloid Leukemia in Remission, Chronic Myelomonocytic Leukemia, Minimal Residual Disease Trial in Seattle (procedure,
Active, not recruiting
- Acute Myeloid Leukemia in Remission
- +5 more
- Allogeneic Bone Marrow Transplantation
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
May 13, 2021
Patients Receiving Mismatched Allogeneic HCT Trial in Germany (immunosuppression)
Terminated
- Patients Receiving Mismatched Allogeneic HCT
-
Mainz, Germany
- +3 more
Jun 29, 2022
Hematologic Diseases, Acute Leukemia in Remission, Chronic Myelogenous Leukemia - Chronic Phase Trial in Ann Arbor (Vorinostat,
Recruiting
- Hematologic Diseases
- +11 more
- Vorinostat
- +5 more
-
Ann Arbor, MichiganUniversity of Michigan Health System
Dec 2, 2021
Multiple Myeloma Trial in United States (procedure, drug, behavioral)
Completed
- Multiple Myeloma
- One Autologous Transplant
- +5 more
-
Birmingham, Alabama
- +35 more
Oct 19, 2021
Non-Neoplastic Hematologic and Lymphocytic Disorder Trial in United States (procedure, biological, drug, other, radiation)
Completed
- Non-Neoplastic Hematologic and Lymphocytic Disorder
- Allogeneic Bone Marrow Transplantation
- +11 more
-
Aurora, Colorado
- +5 more
Jul 21, 2021
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult
Terminated
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +9 more
- Allogeneic Bone Marrow Transplantation
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 4, 2021
Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Maywood (Atorvastatin, Methotrexate,
Withdrawn
- Acute Myeloid Leukemia
- +2 more
- Atorvastatin
- +2 more
-
Maywood, IllinoisLoyola University Medical Center
Apr 23, 2021
Immunodeficiency Syndrome, Severe Aplastic Anemia, Genetic Disorder Trial in Nashville, Seattle (procedure, drug, other,
Terminated
- Immunodeficiency Syndrome
- +2 more
- Allogeneic Bone Marrow Transplantation
- +8 more
-
Nashville, Tennessee
- +2 more
Jan 6, 2021
Myelodysplastic Syndrome, Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia Trial in Washington, Bethesda, Oklahoma City
Completed
- Myelodysplastic Syndrome
- +4 more
- First Allogeneic Bone Marrow Transplant (BMT)
- +9 more
-
Washington, District of Columbia
- +2 more
Mar 16, 2021